Advertisement
Home Blog Page 3544
Wrong-site surgery and retained surgical items still occur

Study Estimates Incidence of Surgical Never Events

0
Current estimates for wrong-site surgery, retained surgical items: 0.09 and 1.32 per 10,000 procedures
For pediatric patients undergoing procedural sedation

Obesity Ups Risks in Pediatric Procedural Sedation

0
Increased risk of adverse respiratory events, frequency of airway interventions with obesity
A shorter course of antibiotic treatment for abdominal infections after surgery may be as equally effective as a longer course

Shorter Antibiotic Course Post Abdominal Surgery May Be Viable

0
No significant between-group differences for four days versus eight days
Children with attention-deficit/hyperactivity disorder often fidget

Children With ADHD May Focus Better When Allowed to Fidget

0
Small study found those who fidgeted intensely performed better on a test
The risk for breast cancer among obese women may be up to 58 percent higher than for normal-weight postmenopausal women

Higher Breast CA Risk Seen for Obese Postmenopausal Women

0
Researchers report the increased risk may be as high as 58 percent
Aerobic workouts may help ease asthma

Aerobic Exercise Tied to Improvement in Asthma

0
Improved airway function in those who had more vigorous workouts
More than 250 of this year's graduating seniors from U.S. medical schools did not match to a residency position

Some Graduating Seniors Not Matching to Residency Positions

0
More than 250 seniors didn't match to residency; reasons include failing exams, poor interview skills
Close to one in 10 American men suffer from depression or anxiety

CDC: Men With Anxiety, Depression Not Getting Treated

0
Young minority males less likely than whites to access mental health care
Lysosomal proteins may offer a way to diagnose and treat Alzheimer's disease earlier

Lysosomal Proteins May Benefit Alzheimer’s Diagnosis, Treatment

0
Could offer possible ways to diagnose, treat disease sooner, researchers say
On Wednesday

FDA Panel Recommends Approval of Second PCSK9 Inhibitor

0
Evolocumab (Repatha) for use in patients at very high risk for high cholesterol